Regadenoson
Product Images NDC 67457-994

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Regadenoson (NDC 67457-994). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical Structure (Image 01)
Chemical structure of regadenoson with a half molecule of water, showing the molecular arrangement of nitrogen, oxygen, and carbon atoms in the compound.*
FDA Label Image

Carton (Image 02)

Carton (Image 02)
Packaging label for Regadenoson Injection 0.4 mg/5 mL (0.08 mg/mL) by Mylan Institutional LLC. The label indicates a 5 mL single-dose prefilled syringe, for intravenous use only, as a pharmacologic stress agent for diagnostic purposes. Includes NDC 67457-994-05, usage instructions, barcodes, and manufacturer details (Mylan Institutional LLC, Morgantown, WV, made in India).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.